COVID-19 Vaccine: Sputnik V 92% Effective Against Coronavirus, Claims Russia

Russia's COVID-19 vaccine Sputnik V vaccine is 92% effective at protecting people from coronavirus according to interim trial results, the country's sovereign wealth fund said on Wednesday.

Russia gave Sputnik V for public use in August, the first country to do so, though the approval comes



before the start of the large-scale trial in September.

The interim results are based on data from the first 16,000 trial participants to receive both shots of the two-dose vaccine, the Russian Direct Investment Fund (RDIF), which has been backing the vaccine and marketing it worldwide, said.